How a single chemical discovery explains the handedness of life
In short: Molecules can be mirror images of each other, yet our bodies only use one version. This fundamental mystery of 'handedness'—or chirality—was solved by the work of Henri Kagan and Kenso Soai, a breakthrough that now ensures the medicines we take are both safe and effective.
Chirality refers to the property of an object being non-identical to its mirror image, much like human hands. In chemistry, molecules exist as enantiomers: pairs of mirror-image structures. While these twins look nearly identical, they can produce vastly different biological effects. For many pharmaceuticals, one 'hand' provides the intended therapeutic benefit, while the other may be inactive or even cause harmful side effects. This distinction is critical because the incorrect isomer can be toxic to the organism. Controlling this molecular handedness is also essential for the production of specific flavours and fragrances.
In the late 1960s, Henri Kagan began questioning whether the chirality of a catalyst—the substance driving a reaction—was directly reflected in the resulting products. By 1985, Kagan discovered a way to manipulate these reactions to create more of one mirror image than previously thought possible. He understood that specific enantiomers attract each other, which enables producing a substance with exceptional optical purity. His 1986 research demonstrated that certain catalysts consist of a metal ion paired with chiral molecules. This mechanism allows for the sequestration of the minor enantiomer, effectively purifying the final product.
The research of Kagan and Kenso Soai provided a mathematical basis for understanding how life achieved homochirality—the state of using only one specific handedness for essential molecules like amino acids and sugars. This work explains how such a preference could emerge spontaneously in nature. Their 202 and 2026 Nobel Prize-winning discoveries in asymmetric organic synthesis and nonlinear effects have since become vital tools for the pharmaceutical industry in designing safer, single-handed molecules. The 2026 Nobel Prize, which includes a 12 million Swedish kronor share, recognizes this century-old solution. This breakthrough follows the 2001 Nobel for catalytic asymmetric synthesis awarded to pioneers like William S. Knowles.
Opens the Intellect+ feed with this card first. Swipe up for the next one.
Sources
- Summary by Intellect · source: Henri Kagan and Kenso Soai win 2026 Chemistry Nobel Prize
- Also: Henri B. Kagan | Biography, 2026 Nobel Prize, Asymmetric Chemical Reaction, & Facts | Britannica
- Also: Henri B. Kagan
- Also: Nobel Prize in Chemistry 2026
To cite this card, link to https://intellectplus.co.uk/app/history-henri-b-kagan.
How we source, check and correct cards: Editorial standards.
General information, not professional advice. Spotted an error? Flag the card or see corrections and complaints.
Intellect Plus is a visual educational discovery platform for exploring fascinating facts and ideas. Brain Food, Not Brain Rot. What is Intellect Plus?
Related
More in Born on this day · More in History · Latest · A–Z · All topics
